StonvexLoading…
StonvexStonvexStonvexCore line items from CUZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $993.82M | $856.76M | $802.87M | $762.29M |
Operating Income | $673.31M | $570.32M | $531.09M | $502.20M |
Net Income | $40.50M | $45.96M | $82.96M | $166.79M |
EPS (Diluted) | $0.24 | $0.30 | $0.55 | $1.11 |
Total Assets | $8.89B | $8.80B | $7.63B | $7.54B |
Total Liabilities | $4.19B | $3.93B | $3.09B | $2.89B |
Cash & Equivalents | $5.72M | $7.35M | $6.05M | $5.14M |
Free Cash Flow OCF − CapEx | $135.04M | $147.50M | $88.84M | $22.93M |
Shares Outstanding | 167.98M | 167.66M | 151.80M | 151.46M |